4//SEC Filing
Anthera Pharmaceuticals Inc 4
Accession 0001214659-16-015225
CIK 0001316175operating
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 9:04 PM ET
Size
5.5 KB
Accession
0001214659-16-015225
Insider Transaction Report
Form 4
THOMPSON JOHN CRAIG
DirectorPresident & CEO
Transactions
- Award
Stock option (right to buy)
2016-12-06+300,000→ 300,000 totalExercise: $1.47Exp: 2026-12-06→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]This stock option vests over four years as follows: 25% of the stock options shall vest one year following the vesting commencement date, with the remaining 75% of the stock options vesting in 36 equal monthly installments thereafter. The vesting commencement date is December 6, 2016.
Documents
Issuer
Anthera Pharmaceuticals Inc
CIK 0001316175
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001316175
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 9:04 PM ET
- Size
- 5.5 KB